Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease).

Martin-Rufino JD, Lozano FS, Redondo AM, Villaron EM, Rueda R, Fernandez-Samos R, Sanchez-Guijo F.

Stem Cell Res Ther. 2018 May 30;9(1):150. doi: 10.1186/s13287-018-0901-6.

2.

Conserved Bacterial-Binding Peptides of the Scavenger-Like Human Lymphocyte Receptor CD6 Protect From Mouse Experimental Sepsis.

Martínez-Florensa M, Català C, Velasco-de Andrés M, Cañadas O, Fraile-Ágreda V, Casadó-Llombart S, Armiger-Borràs N, Consuegra-Fernández M, Casals C, Lozano F.

Front Immunol. 2018 Apr 12;9:627. doi: 10.3389/fimmu.2018.00627. eCollection 2018.

3.

Clinical and experimental evidence for targeting CD6 in immune-based disorders.

Consuegra-Fernández M, Lin F, Fox DA, Lozano F.

Autoimmun Rev. 2018 May;17(5):493-503. doi: 10.1016/j.autrev.2017.12.004. Epub 2018 Mar 9. Review.

PMID:
29526637
4.

C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis.

Martín-Granado V, Ortiz-Rivero S, Carmona R, Gutiérrez-Herrero S, Barrera M, San-Segundo L, Sequera C, Perdiguero P, Lozano F, Martín-Herrero F, González-Porras JR, Muñoz-Chápuli R, Porras A, Guerrero C.

Oncotarget. 2017 Nov 6;8(67):110994-111011. doi: 10.18632/oncotarget.22339. eCollection 2017 Dec 19.

5.

Immunomodulatory effects of soluble CD5 on experimental tumor models.

Simões IT, Aranda F, Carreras E, Andrés MV, Casadó-Llombart S, Martinez VG, Lozano F.

Oncotarget. 2017 Nov 20;8(64):108156-108169. doi: 10.18632/oncotarget.22564. eCollection 2017 Dec 8.

6.

Corrigendum: Commentary: The Scavenger Receptor SSc5D Physically Interacts with Bacteria through the SRCR-Containing N-Terminal Domain.

Lozano F, Martínez-Florensa M.

Front Immunol. 2017 Nov 29;8:1660. doi: 10.3389/fimmu.2017.01660. eCollection 2017.

7.

Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.

Consuegra-Fernández M, Julià M, Martínez-Florensa M, Aranda F, Català C, Armiger-Borràs N, Arias MT, Santiago F, Guilabert A, Esteve A, Muñoz C, Ferrándiz C, Carrascosa JM, Pedrosa E, Romaní J, Alsina M, Mascaró-Galy JM, Lozano F.

Cell Mol Immunol. 2017 Dec 11. doi: 10.1038/cmi.2017.119. [Epub ahead of print]

PMID:
29225340
8.

Plain packaging of tobacco products in the European Union: an EU success story?

Vardavas C, Filippidis FT, Ward B, Faure M, Jimenez-Ruiz C, Gratziou C, Katsaounou P, Lozano F, Behrakis P, Radu-Loghin C; European Respiratory Society (ERS) Tobacco Control Committee; European Network for Smoking and Tobacco Prevention (ENSP) Scientific Committee.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701232. doi: 10.1183/13993003.01232-2017. Print 2017 Nov. No abstract available.

PMID:
29167302
9.

Cytokines as therapeutic targets in primary Sjögren syndrome.

Retamozo S, Flores-Chavez A, Consuegra-Fernández M, Lozano F, Ramos-Casals M, Brito-Zerón P.

Pharmacol Ther. 2018 Apr;184:81-97. doi: 10.1016/j.pharmthera.2017.10.019. Epub 2017 Oct 29. Review.

PMID:
29092775
10.

Erratum for Martínez-Florensa et al., "Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis".

Martínez-Florensa M, Consuegra-Fernández M, Aranda F, Armiger-Borràs N, Di Scala M, Carrasco E, Pachón J, Vila J, González-Aseguinolaza G, Lozano F.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01997-17. doi: 10.1128/AAC.01997-17. Print 2017 Nov. No abstract available.

11.

Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis.

Consuegra-Fernández M, Isamat M, Lozano F.

Front Immunol. 2017 Sep 29;8:1217. doi: 10.3389/fimmu.2017.01217. eCollection 2017. No abstract available.

12.

Gut microbiota metabolites for sweetening type I diabetes.

Aljutaily T, Consuegra-Fernández M, Aranda F, Lozano F, Huarte E.

Cell Mol Immunol. 2018 Feb;15(2):92-95. doi: 10.1038/cmi.2017.65. Epub 2017 Jul 31. No abstract available.

PMID:
28757611
13.

Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses.

Carrasco E, Escoda-Ferran C, Climent N, Miró-Julià C, Simões IT, Martínez-Florensa M, Sarukhan A, Carreras E, Lozano F.

Front Immunol. 2017 Jun 30;8:769. doi: 10.3389/fimmu.2017.00769. eCollection 2017.

14.

Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance.

Consuegra-Fernández M, Martínez-Florensa M, Aranda F, de Salort J, Armiger-Borràs N, Lozano T, Casares N, Lasarte JJ, Engel P, Lozano F.

Front Immunol. 2017 May 30;8:594. doi: 10.3389/fimmu.2017.00594. eCollection 2017.

15.

Volumetric arc therapy for total scalp irradiation: case report for a recurrent basal cell carcinoma of the scalp.

Lozano F, Perez N, Iglesias A, Xu X, Amendola MA, Scott M, Companioni E, Amendola BE.

Ecancermedicalscience. 2017 May 11;11:737. doi: 10.3332/ecancer.2017.737. eCollection 2017.

16.

Mannose-binding lectin-deficient genotypes as a risk factor of pneumococcal meningitis in infants.

Bautista-Rodriguez C, Launes C, Jordan I, Andres M, Arias MT, Lozano F, Garcia-Garcia JJ, Muñoz-Almagro C.

PLoS One. 2017 May 31;12(5):e0178377. doi: 10.1371/journal.pone.0178377. eCollection 2017.

17.

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

Vasquez M, Simões I, Consuegra-Fernández M, Aranda F, Lozano F, Berraondo P.

Eur J Immunol. 2017 Jul;47(7):1108-1118. doi: 10.1002/eji.201646903. Epub 2017 Jun 12. Review.

18.

Commentary: The Scavenger Receptor SSc5D Physically Interacts with Bacteria through the SRCR-Containing N-Terminal Domain.

Lozano F, Martínez-Florensa M.

Front Immunol. 2017 Mar 28;8:366. doi: 10.3389/fimmu.2017.00366. eCollection 2017. No abstract available. Erratum in: Front Immunol. 2017 Nov 29;8:1660.

19.

Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis.

Martínez-Florensa M, Consuegra-Fernández M, Aranda F, Armiger-Borràs N, Di Scala M, Carrasco E, Pachón J, Vila J, González-Aseguinolaza G, Lozano F.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01391-16. doi: 10.1128/AAC.01391-16. Print 2017 Jan. Erratum in: Antimicrob Agents Chemother. 2017 Oct 24;61(11):.

20.

Oral Administration of Pentoxifylline Reduces Endometriosis-Like Lesions in a Nude Mouse Model.

Perelló M, González-Foruria I, Castillo P, Martínez-Florensa M, Lozano F, Balasch J, Carmona F.

Reprod Sci. 2017 Jun;24(6):911-918. doi: 10.1177/1933719116673198. Epub 2016 Oct 12.

PMID:
27738175

Supplemental Content

Loading ...
Support Center